A Study of AK0529 in Adults Patients Hospitalized With RSV Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 20, 2023

Primary Completion Date

June 28, 2024

Study Completion Date

June 28, 2024

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

AK0529

Active Substance: AK0529, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral, fasting

DRUG

AK0529

Active Substance: AK0529, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral with meal

DRUG

Placebo

Active Substance: Placebo, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral with meal or fasting

Trial Locations (42)

100000

Peking University Shougang Hospital, Beijing

100005

Beijing Hospital, Beijing

100029

China-Japan Friendship Hospital, Beijing

200065

Tongji Hospital of Tongji University, Shanghai

200437

Yueyang Hospital Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai

201203

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai

210004

Jiangsu Provincial Hospital of Chinese Medicine, Nanjing

213004

Changzhou Second People's Hospital, Changzhou

312035

Shaoxing People's Hospital, Shaoxing

314408

Zhejiang Provincial People's Hospital, Hangzhou

315010

Ningbo First Hospital, Ningbo

317099

Taizhou Hospital of Zhejiang Province, Taizhou

350004

The First Affiliated Hospital of Fujian Medical University, Fuzhou

510120

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

511486

Guangzhou Panyu Central Hospital, Guangzhou

518116

Longgang Central Hospital of Shenzhen, Shenzhen

524037

Central People's Hospital of Zhanjiang, Zhanjiang

528399

Shunde Hospital of Southern Medical University, Shunde

610044

Chengdu Seventh People's Hospital, Chengdu

Unknown

The Second Perople's Hospital of Hefei, Hefei

Huangshan City People's Hospital, Huangshan City

Quanzhou First Hospital, Quanzhou

Gansu People's Hospital, Lanzhou

The Second Nanning People's Hospital, Nanning

Guizhou People's Hospital, Guiyang

Hebei Chest Hospital, Shijiazhuang

Harbin Medical University Affiliated Fourth Hospital, Harbin

The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin

The Sixth People's Hospital of Zhengzhou, Zhengzhou

Wuhan Fourth Hospital, Wuhan

Xiangyang Center Hospital, Xiangyang

Yueyang Central Hospital, Yueyang

The First Affilited Hospital of Nanchang University, Nanchang

Jilin Province People's Hospital, Changchun

The First Clinical College / Liaoning Hospital of TCM, Shenyang

Inner Mongolia Autonomous Region People's Hospital, Hohhot

The Affiliated Hospital of Qingdao University, Qingdao

Weifang NO.2 People's Hospital, Weifang

Sencond Hospital of Shanxi Medical University, Taiyuan

The First Affiliated Hospital of Xi'an Medical University, Xi’an

The First Hospital of Kunming, Kunming

The First People's Hospital of Yunnan Province, Kunming

All Listed Sponsors
lead

Shanghai Ark Biopharmaceutical Co., Ltd.

INDUSTRY